Effects of Botulinum Toxin in Cervical Dystonia

NCT01056861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2015-04-17

No results posted yet for this study

Summary

Botulinum toxin injection in the contracting muscles has proven to be a safe and effective method of relieving pain and lessening dystonic posturing. The current hypothesis is that botulinum toxin works on altering sensory input in the central nervous system in addition to its effects on the neuromuscular junction.

Magnetoencephalography (MEG)of brain has been used in dystonia such as writer's cramp and musician's hand dystonia. However, no study has investigated the correlation of central signal changes via magnetoencephalography before and after treatment with botulinum in torticollis patients. Prior studies using somatosensory potentials indicated the possibility of differential activation of precentral cortex in patients with cervical dystonia. Cervical dystonia may result from a disorder of both cortical excitability and intracortical inhibition. The investigators hypothesis is that botulinum injection modulates central inhibition which improves clinical outcome for torticollis.

Conditions

  • Torticollis
  • Cervical Dystonia

Interventions

DRUG

Botulinum Toxin A

Not exceeding a total dose of 400 units, once every three months.

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY
  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Naganand Sripathi, MD · Henry Ford Health System

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056861 on ClinicalTrials.gov